CCN2 and cancer: In addition, the expression of connective tissue growth factor (CTGF) [43], which is a direct target of angiogenesis-promoting medium and the TGFβ signalling pathway, is significantly reduced in METTL14/ALKBH5-silenced cancer cells [27].